Market for prescription drugs for acne Acne is a common disease that leads to the formation of lesions or pimples. The disease is charact...
Market for prescription drugs for acne
Acne is a common disease that leads to the formation of lesions or pimples. The disease is characterized by an overproduction of sebum due to the high production of the male hormone androgen in puberty. The hyperactivity of the hormone leads to excessive sebum production. Sebum is an oily substance that forms in the sebaceous gland just below the surface of the skin. Sebum is widely recognized as a natural moisturizer for the skin. Excessive sebum secretion, however, leads to the appearance of pimples. Acne is characterized by the formation of nodules (papules large), blackheads (blackheads and pimples), seborrhoea (scaly red skin), scars and pimples.
Request a report brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12266
Market for prescription drugs for acne: segmentation
The market for prescription drugs for acne can be classified according to various drugs available on the market. Accutane (isotretinoin), Desquam-E (benzoyl peroxide), Cleocin T (clindamycin phosphate), benzamycin, topical erythromycin (A / T / S, erythetia, t-stat), Retin-A (tretinoin) and Minocin (hydrochloride) minocycline) are several acne medications in the market. In addition to the above medicines, tretinoin (Retin-A) is another popular acne treatment available in the form of gel and topical creams. In addition, all of the above medicines are not prescription and can be used without consultation with a doctor without a prescription. However, isotretinoin (Accutane), available in capsule form, is only available on prescription. In addition, combined antineoplastic agents such as BenzaClin, which combine clindamycin with benzoyl peroxide for the effective treatment of acne, are now available.
Market for Prescription Drugs for Acne: Geographic Dynamics
The market for prescription drugs for acne can also be divided into regions in North America, Europe, the Asia-Pacific region and the rest of the world. North America currently has the largest share of the world market for prescription acne medications. The dominance of this region has been proven by the presence of a large number of pharmaceutical manufacturers that allows a slight penetration of the market, a high level of awareness and a higher prevalence of acne. Ranbaxy Labs recently launched Absorica Capsules (isotretinoin) in the US market. This product is also a flagship brand in the product portfolio of Ranbaxy Dermatology. In the Asia-Pacific region, significant growth is expected in the future due to changes in dietary habits, lifestyle and increased patient awareness. In addition, the increasing prevalence of pharmaceutical agents in Asia would increase Asia's market share in the acne medicines market. However, the side effects associated with the consumption of acne medications are an important factor that could hamper the growth of this market.
The report provides a thorough assessment of the market. It relies on detailed qualitative ideas, historical data and verifiable projections of market size. The projections presented in the report have been compiled using proven research methods and hypotheses. The research report serves as a benchmark for analysis and information on all aspects of the market, including regional markets, technologies, types and applications.
Pre-book:
https://www.transparencymarketresearch.com/checkout.php?rep_id=12266<ype=S
